… SARS-CoV-1. Our results highlight the feasibility of using the VSV-SARS-CoV-2 system
to develop SARS-CoV-2 antibody … strategies to address the mutational escape of SARS-CoV-2. …

… These bispecific NAbs neutralize wild-type SARS-CoV-2, its VOCs, and escape mutants …
bispecific NAbs are promising next-generation cost-effective therapeutics against SARS-CoV-2 …

… both SARS-CoV-1 and WT SARS-CoV-2. Based on X-ray crystallography, we engineered a
bispecific … Bispecific antibody 2-3-Fc designed by fusing aSA3-Fc to nonoverlapping aRBD-2 …

… a convalescent SARS-CoV-1 patient and a SARS-CoV-2 … of a single neutralizing antibody,
the SARS-CoV-2 strain may … monoclonal antibody combination against SARS coronavirus …

… bispecific for the RBD of SARS-CoV-2 and human serum albumin (HSA). This bispecific
antibody exhibited potent inhibitory activity against the wild type and variants of SARS-CoV-2, …

… 34 to produce bsAbs that neutralize SARS-CoV and SARS-CoV-2 variants, … SARS-CoV-2-specific
neutralizing antibodies with 36 broader antibodies that also neutralize SARS-CoV. We …

… SARS-CoV. Furthermore, we demonstrate the therapeutic potential of the nanobody against
SARS-CoV… This naturally elicited bispecific monomeric nanobody establishes an uncommon …

… -format IgG1-like bispecific antibody 11 resulting from the … CoV-X2 in vitro, we first used
SARS-CoV-2 pseudoviruses 16 . The bispecific neutralized pseudovirus carrying wild-type SARS…

… Citation133 BsAbs recognizing several epitopes of the NP antigen of SARS coronavirus (causing
severe acute respiratory syndrome) and binding to horseradish peroxidase were used …

… antibodies against SARS CoV S1 antigen were generated by hybridomatechnology. ►
Bispecific antibody … Mono- and bispecific antibodies were evaluated by sandiwichELISA for …